Sarma Arnabjyoti Deva, Devi Moitrayee
Faculty of Paramedical Sciences, Assam Down Town University, Gandhinagar, Panikhaiti, Guwahati, Assam, India.
Hormones (Athens). 2025 Mar 21. doi: 10.1007/s42000-025-00644-4.
Diabetes, a chronic metabolic disorder characterized by ineffective blood sugar regulation, affects millions of people worldwide, with its prevalence projected to more than double in the next 30 years. Diabetes-related complications are severe and sometimes life-threatening, including cardiovascular disease, kidney failure, and blindness, this posing a significant challenge, especially in low- and middle-income countries. This study explored the integration of artificial intelligence (AI) into diabetes management, emphasizing its transformative potential in healthcare.
To evaluate the role of AI in enhancing diabetes management and to identify the challenges and opportunities associated with its implementation.
A systematic review following the PRISMA guidelines was conducted by analyzing the literature published from January 2020 to May 2024. This review focused on the application of AI in diabetes diagnosis, personalization of treatment, and predictive analytics.
The ability of AI to analyze large datasets and identify complex patterns shows promise in improving diabetes management. AI-assisted diagnostic tools enhance diagnostic accuracy, enable early detection, and support personalized treatment plans, thereby reducing human error. AI has also facilitated research breakthroughs in genomics and drug discovery. Furthermore, AI-powered predictive analytics enhances clinical decision-making and supports precision medicine. Despite these advancements, challenges remain in such issues as data quality, technical infrastructure, and ethical considerations, emphasizing the need for responsible AI development that focuses on patient privacy and transparency.
AI has significant potential to revolutionize diabetes management and healthcare delivery. Combining AI's analytical processes with clinical expertise can substantially improve the quality of care. Addressing data, technology, and ethical challenges is crucial for fully harnessing AI's potential, thereby enhancing patient well-being and healthcare outcomes.
糖尿病是一种以血糖调节无效为特征的慢性代谢紊乱疾病,全球数以百万计的人受其影响,预计在未来30年其患病率将增加一倍以上。糖尿病相关并发症严重,有时甚至危及生命,包括心血管疾病、肾衰竭和失明,这构成了重大挑战,尤其是在低收入和中等收入国家。本研究探讨了人工智能(AI)在糖尿病管理中的整合,强调其在医疗保健中的变革潜力。
评估人工智能在加强糖尿病管理中的作用,并确定其实施相关的挑战和机遇。
按照PRISMA指南进行了一项系统综述,分析了2020年1月至2024年5月发表的文献。该综述重点关注人工智能在糖尿病诊断、治疗个性化和预测分析中的应用。
人工智能分析大型数据集和识别复杂模式的能力在改善糖尿病管理方面显示出前景。人工智能辅助诊断工具提高了诊断准确性,实现了早期检测,并支持个性化治疗方案,从而减少人为错误。人工智能还推动了基因组学和药物发现方面的研究突破。此外,人工智能驱动的预测分析增强了临床决策并支持精准医学。尽管取得了这些进展,但在数据质量、技术基础设施和伦理考量等问题上仍存在挑战,强调需要负责任地开发人工智能,注重患者隐私和透明度。
人工智能在彻底改变糖尿病管理和医疗服务提供方面具有巨大潜力。将人工智能的分析过程与临床专业知识相结合可以大幅提高护理质量。应对数据、技术和伦理挑战对于充分发挥人工智能的潜力至关重要,从而提高患者福祉和医疗结果。